1. Home
  2. Buyout

Category: Software and Hi-Tech

Capital Square 1031 earns investors a 253.31% total return on equity after portfolio sale

Capital Square 1031 has earned its investors a 253.31% total return on equity or a 28.81% annualised return through the sale of Candleglow Apartments.

Most Forwarded: Opalesque most forwarded article – week 42: And, finally Wait until he's grown up…!

From BizarreNews: A Tennessee boy is being honored by Guinness World Records for an unusual accomplishment: achieving nuclear fusion just hours before his 13th birthday. Jackson Oswalt, now 15, of Memphis was dubbed by Guinness

Innova to buy PayPoint's Romanian division

Polish private equity firm Innova Capital has signed an agreement to acquire PayPoint's Romanian business PayPoint Services for £47m.

TPG collects $2.17bn so far for rise fund

The firm reduced its fundraising target after a top executive was caught in the 2019 college-cheating scandal

Pureos Bioventures leads CHF 15.2m round for Araris

Pureos Bioventures has led a CHF 15.2m seed round for Switzerland-based biotechnology company Araris Biotech.

UVC Partners announces third fund

UVC Partners has launched its third fund, UnternehmerTUM Fonds III, with a target of €150m.

HTGF, Evonik exit Synoste to trade

High-Tech Gründerfonds (HTGF) and Evonik Venture Capital have sold their stakes in Finnish company Synoste to US-based medical device manufacturer Globus Medical.

Vista-backed Finastra acquires Doorr

Vista Equity Partners portfolio company Finastra has acquired Doorr.

LLCP acquires metrology specialist NMI

Levine Leichtman Capital Partners (LLCP) has bought Dutch legal metrology specialist NMI Certin from First Dutch Innovations (FDI).

Five Arrows, TA-backed RLDatix acquires Verge Health

Five Arrows and TA Associates portfolio company RLDatix has acquired Verge Health, a developer of software for governance, risk and compliance in healthcare companies.

LLCP buys Triskelion

Levine Leichtman Capital Partners (LLCP) has acquired food testing specialist Triskelion from First Dutch Innovations (FDI).

Vaaka Partners buys engineering firm A-Insinoorit

Finnish private equity firm Vaaka Partners has acquired a majority stake in engineering and consulting firm A-Insinoorit (Ains Group).

Pension giant freezes Apollo commitments as firm launches review of CEO Black’s ties to Epstein

US pension giant PSERS has put a freeze on new commitments to private equity major Apollo Global Management following the revelation that founder and CEO Leon Black wired up to $75m in payments to convicted

McAfee IPO priced toward low end of expected range

The cybersecurity software company backed by private equity firms TPG and Thoma Bravo

TPG, Thoma Bravo-backed McAfee hits $8.6bn valuation in return to public market

Private equity-backed cybersecurity major McAfee has hit an $8.6bn valuation through its return to the public market through an IPO.

Oakley acquires WindStar Medical

Oakley Capital has acquired over-the-counter health products company WindStar Medical from General Atlantic-backed NuCom Group, the e-commerce subsidiary of ProSiebenSat.

Omnes reinvests in recycled wood pellet maker Biosyl a year after initial investment

Omnes has completed its eighth sponsorless deal through its reinvestment in wood pellet manufacturer Biosyl, a year after it first invested in the business.

Oakley Capital buys Windstar Medical for €280m

The provider of non-prescription healthcare products is expected to generate over €120m in revenues this year

SVB Capital eyes up to $250m for fifth early-stage investment fund

Venture capital investor SVB Capital is looking to raise up to $250m for its fifth early-stage investment fund.

Pilot Growth Equity co-founder, Bluebird Capital founder DeLoche eyes up to $200m for debut Invictus Growth Partners fundraise

A pair of former Pilot Growth Equity veterans are hoping to raise up to $200 for their debut Invictus Growth Partners fund.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.